What is the MPH.V share price today?

This page shows the latest available Medicure Inc. (MPH.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Medicure Inc. listed?

Medicure Inc. trades on the TSX Venture Exchange under the symbol MPH.V, ISIN CA58469E4085.

How large is Medicure Inc.?

Its market capitalisation is approximately 26.09M CAD, based on the latest available price and share count from our data provider.

TSX Venture Exchange (TSXV) · MPH.V · ISIN CA58469E4085

Medicure Inc.

2.66 CAD

−0.03(−1.12%)

Previous close · Sep 18, 10:28 ET

Data last updated: Sep 18, 10:28 ET (1 d ago)· Delayed exchange data

Medicure Inc. (MPH.V) trades on the TSX Venture Exchange and operates in the Drug Manufacturers - Specialty & Generic industry. Its market capitalisation is approximately 26.09M CAD. The company reports around 25 employees. Its ISIN is CA58469E4085. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

TSX Venture Exchange (TSXV)

ISIN

CA58469E4085

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Market cap

27.76M CAD

Employees

Previous close

2.69 CAD

Day range

2.66 – 2.66

52-week range

0.85 – 2.74

Volume

1.7K

50-day average

1.62 CAD

200-day average

1.27 CAD

Asset type

Equity

About Medicure Inc.

Medicure Inc. is a biopharmaceutical firm focused on developing, researching, and commercializing therapeutic solutions for cardiovascular conditions across Canada and the United States. Its product portfolio includes AGGRASTAT, an injectable glycoprotein GP IIb/IIIa receptor antagonist prescribed for acute coronary syndromes, such as unstable angina and non-Q-wave myocardial infarction. The company also provides ZYPITAMAG, a medication used to manage primary hyperlipidemia and mixed dyslipidemia. Additionally, Medicure offers the ReDS system, a non-invasive medical device designed to measure lung fluid levels, aiding in the management of congestive heart failure. Another key offering is Sodium Nitroprusside injection, utilized for rapidly lowering blood pressure during hypertensive crises in both adult and pediatric patients, inducing controlled hypotension for surgical bleeding reduction, and treating acute congestive heart failure. These products are made available through both retail pharmacy networks and online platforms. Established in 1997, Medicure Inc. is headquartered in Winnipeg, Canada.

Company website

Frequently asked

What is the MPH.V share price today?: This page shows the latest available Medicure Inc. (MPH.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Medicure Inc. listed?: Medicure Inc. trades on the TSX Venture Exchange under the symbol MPH.V, ISIN CA58469E4085.
How large is Medicure Inc.?: Its market capitalisation is approximately 26.09M CAD, based on the latest available price and share count from our data provider.

All Medicure Inc. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.